Lamstein Joshua R 4
4 · Scopus BioPharma Inc. · Filed Nov 26, 2021
Insider Transaction Report
Form 4
Lamstein Joshua R
DirectorChairman
Transactions
- Other
W Warrants
2021-11-23−3,000,000→ 0 total(indirect: By LLC)Exercise: $4.00From: 2021-10-01Exp: 2026-09-30→ B Unit (3,000,000 underlying)
Footnotes (1)
- [F1]The Reporting Person is a member and co-manager of HCFP/Capital Partners 18B-2 LLC ("HCFP 18B-2"). On November 23, 2021, HCFP 18B-2, pursuant to a Warrant Contribution Agreement by and between the Issuer and HCFP 18B-2, agreed to contribute its 3,000,000 W Warrants back to the Company in exchange for the Company cancelling a $1.5 million contingent promissory note, including any and all interest, owed by HCFP 18B-2 to the Company.